Acute Kidney Injury with Characteristics of Rapidly Progressive Glomerulonephritis Due to Suspected IgA Nephropathy:
A Case Report
Abstract
Acute kidney damage (AKI) in glomerular disease is typically characterized by rapidly progressive glomerulonephritis (RPGN). RPGN in IgA nephropathy is uncommon, occurring in less than 10% of patients. RPGN presents diagnostic issues in resource-limited settings. A 34-year-old male patient had acute kidney injury with RPGN characteristics based on clinical symptoms of hypertension, pitting edema, anuria, and hematuria after an upper respiratory tract infection, as well as laboratory findings of proteinuria, persistent microscopic hematuria, and positive erythrocyte casts. Serum creatinine levels rose sharply. Corticosteroids, antihypertensives, and hemodialysis resulted in clinical improvement and fast kidney function recovery. Due to limited resources, no kidney biopsy was conducted. This case provides a diagnostic approach to RPGN in IgA nephropathy in resource-limited settings, along with comprehensive therapy.
Downloads
References
Sethi S, Vriese ASD, Fervenza FC. Acute glomerulonephritis. Lancet. 2022;399(10335):1646–63. doi:10.1016/s0140-6736(22)00461-5
Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, et al. Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention. Front Med. 2021;7:582272. doi:10.3389/fmed.2020.582272
Perše M, Večerić-Haler Ž. The Role of IgA in the Pathogenesis of IgA Nephropathy. Int J Mol Sci. 2019;20(24):6199. doi:10.3390/ijms20246199
Knoppova B, Reily C, King RG, Julian BA, J N, Green TJ. Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment. J Clin Med. 2021;10(19):4501. doi:10.3390/jcm10194501
Schena FP, Nistor I. Epidemiology of IgA Nephropathy: A Global Perspective. Semin Nephrol. 2018;38(5):435–442. doi:10.1016/j.semnephrol.2018.05.013
Rojas-Rivera J, Fernández-Juárez G, Praga M. Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease? Clin Kidney J. 2015;8(5):477–481. doi:10.1093/ckj/sfv095
Pimentel PV de S, Freitas HC, Leite MDB, Lima RSA, Barreto DMS, Teixeira AC, et al. Rapidly progressive glomerulonephritis and acute kidney injury associated with cocaine use - Case report. J Bras Nefrol. 2021;43(2):283–287. doi:10.1590/2175-8239-jbn-2020-0034
Moorani KN, Aziz M, Amanullah F. Rapidly progressive glomerulonephritis in children. Pak J Med Sci. 2022;38(2):417–425. doi:10.12669/pjms.38.icon-2022.5774
J L, E N. Glomerular diseases in Harrison’s Nephrology and Acid-base disorder. McGraw-Hill Education; 2013.
Group KDIGO (KDIGO) GDW. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1–S276. doi:10.1016/j.kint.2021.05.021
Arimura Y, Muso E, Fujimoto S, Hasegawa M, Kaname S, Usui J, et al. Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis. Clin Exp Nephrol. 2016;20(3):322–341. doi:10.1007/s10157-015-1218-8
Angela KAP, Sutarka IN. Kecurigaan rapid progressive glomerulonephritis akibat nefropati IgA : Sebuah laporan kasus. Intisari Sains Medis. 2022;13(3):547–550. doi:10.15562/ism.v13i3.1424
Morimoto N, Mori T, Shioji S, Taguchi T, Watanabe H, Sakai K, et al. Rapidly progressive IgA nephropathy with membranoproliferative glomerulonephritis-like lesions in an elderly man following the third dose of an mRNA COVID-19 vaccine: a case report. BMC Nephrol. 2023;24(1):108. doi:10.1186/s12882-023-03169-3
Akkad I, Ortiz A, Hecht M. Rapidly Progressive IgA Nephropathy: A Case Report With Review of Clinical Presentation, Prognostic Factors and Therapeutic Modalities. J Med Cases. 2016;7(6):230–233. doi:10.14740/jmc2498w
Copyright (c) 2024 Indonesian Journal of Kidney and Hypertension

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Indonesian Journal of Kidney and Hypertension agree to the following terms:
- Authors retain copyright and grant Indonesian Journal of Kidney and Hypertension right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Indonesian Journal of Kidney and Hypertension.
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Indonesian Journal of Kidney and Hypertension.